Abstract
The incidence of childhood brain tumors appears to be on the rise caused in part by improvements in neuroimaging and its increased availability. Current protocols for treatment of childhood brain tumors are utilizing chemotherapy more extensively in addition to and in lieu of radiotherapy to improve survival for tumors such as medulloblastoma and high grade astrocytoma, and to lessen treatment related morbidity in infants with malignant brain tumors and in older children with standard risk medulloblastomas and germ cell tumors. The increasing understanding of the molecular events that lead to oncogenesis will help unravel the causes and improve therapy for a group of illnesses that cause significant neurologic morbidity and mortality.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
